Merck Expands Portfolio of Certified Reference Materials for Applied Diagnostics and Testing
Two new products support the identification of the industry-standard alcohol biomarker with high sensitivity
Seven new products ensure accurate identification of omega-3 and omega-6 fatty acids for diagnostic testing
Darmstadt, Germany — Merck, a leading science and technology company, today announced the expansion of its portfolio of Cerilliant® certified reference materials (CRMs) with nine new Certified Spiking Solutions® used in laboratories around the world. The premade stock solutions can be spiked into matrices to create accurate controls and calibrators for applied diagnostics and testing, ensuring reliability in the identification and quantification of drugs and endogenous biomarkers.
“Our portfolio of certified reference materials leverages the latest research and techniques from around the world to meet the ever-changing needs of the health care industry,” said Theresa S. Creasey, Head of Strategy, Marketing and Innovation at the life science business of Merck. “Merck’s comm

